Roche targets mid-single digit sales growth in 2025 with robust pipeline momentum
Q4 2024 Management View CEO Thomas Schinecker emphasized that 2024 was an "excellent year," with overall group sales growing ...
Insulin Pen And Pump Market Expansion Forecasted At 6.97% CAGR To 60.0 Billion USD By 2032 Abbott Laboratories, Roche
Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...
pharmaphorum3d
Roche joins quest to create closed loop insulin device
In this instance, the partnership will combine Senseonics’ Eversense continuous glucose monitor (CGM), TypeZero’s InControl algorithms, and Roche’s Accu-Chek Insight Insulin Pump.
Hosted on MSN25d
Here’s Why Senseonics Holdings, Inc. (NYSE:SENS) Is Among the Best Diabetes Stocks to Buy Under $10
AI is now being included in CGM technology. For instance, Roche unveiled Accu-Chek SmartGuide, a revolutionary predictive AI-powered CGM device. Roche Diabetes Care Chief Medical Officer Julien ...
Yahoo Finance25d
Here’s Why Senseonics Holdings, Inc. (NYSE:SENS) Is Among the Best Diabetes Stocks to Buy Under $10
For instance, Roche unveiled Accu-Chek SmartGuide, a revolutionary predictive AI-powered CGM device. Roche Diabetes Care Chief Medical Officer Julien Boisdron described it as “a solution more ...